Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $23,551,110 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 150 grants at over 100 hospitals in 17 countries.
![](/media/4862/julia-gala.jpg)
Cincinnati Children's Hospital – $50,000
$50,000.00
May 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma
![](/media/2413/siope.png)
SIOPe DIPG/DMG Registry – $779,018
$779,018.00
March 2022
Renewal of the European DIPG/DMG Registry
![](/media/3781/pbtc-logo.png)
Funding of PBTCF 2022 - $25,000
$25,000.00
January 2022
![](/media/3143/bakhous_tannous.jpg)
Massachusetts General Hospital – $50,000
$50,000.00
November 2021
Targeted Protein Degradation for DIPG Therapy
![](/media/3676/connect.jpg)
CONNECT2007 - $345,794
$345,794.00
September 2021
Phase I/II Study of Lutathera in Pediatric and Young Adult Patients with Recurrent and/or Progressive High-Grade Central Nervous System (CNS) Tumors and Meningiomas which Express Somatostatin Type 2A Receptors and Demonstrate Uptake on DOTATATE
![](/media/3676/connect.jpg)
CONNECT2109A - $705,764
$705,764.00
September 2021
CONNECT2109A: A molecularly-guided phase II study of ribociclib and everolimus in children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG)
![](/media/3676/connect.jpg)
CONNECT Consortium - $278,619
$278,619.00
September 2021
Immuno-Modulation to Treat Poor-Prognosis Pediatric Brain Tumors
![](/media/3096/jones_chris.jpg)
Institute of Cancer Research – $113,747
$113,747.00
September 2021
Co-Culture Disruptor Screens to Target Cell-Cell Interactions in DMG
![](/media/3096/jones_chris.jpg)
Institute of Cancer Research – $498,716
$498,716.00
September 2021
Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG) - An International Connect Consortium Preclinical / Clinical
![](/media/3872/ziegler.jpg)
Sydney Children’s Hospital – $195,327
$195,327.00
September 2021
Phase I/II Study of Oral DFMO and AMXT1501 for DIPG/DMG
![](/media/3142/adam_green.jpg)
Children’s Hospital of Colorado – $200,000
$200,000.00
September 2021
Multimodality, Combination Treatment Strategy for DIPG/DMG
![](/media/4423/upton.png)
Children's Cancer Institute – $50,000
$50,000.00
September 2021
Developing Novel Combination Therapies for Diffuse Intrinsic Pontine Glioma
![](/media/4445/biplab-dasgupta.jpg)
Cincinnati Children's Hospital – $200,000
$200,000.00
September 2021
Targeting Purine Synthesis and One Carbon Metabolism in DIPG
![](/media/4455/pollack-ian.jpg)
UPMC Children's Hospital – $50,000
$50,000.00
September 2021
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance
![](/media/4486/genovesi.jpeg)
University of Queensland Diamantina Institute – $100,000
$100,000.00
September 2021
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma